Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Remember GvHD?
View:
Post by TheKneeH on Sep 03, 2021 10:59am

Remember GvHD?

For those who oroginally were on Kaly and the GvHD bandwagon

https://ca.finance.yahoo.com/news/cellect-biotechnology-announces-apograft-bone-202000784.html
Comment by Chritters on Sep 03, 2021 1:56pm
I thought it was being sold back to Talent!! Probably never had it in the first place,
Comment by TheKneeH on Sep 03, 2021 3:22pm
It is back to Talent. This article doesn't refer to Kaly/Claritas. This other company made a GvHD related announcement, and the stock went up around 25% ealier today. When Kaly/Claritas announced they were getting rid of their GvHD program, I seem to recal them mentionning something like "it wasn't worth pursuing..." just saying
Comment by Chritters on Sep 03, 2021 3:26pm
Yes correct but Kaly said they were the only ones with a Licence for GVHD!! Obviously like everything else you here its BS
Comment by TheKneeH on Sep 03, 2021 4:05pm
Pretty sure Kaly were the only ones who had a license to use the Talent IP. This other company is not using the same technology. The only point I was trynig to make is that there is demand for GvHD (Kaly said that repeatedly in the past). Anyway, Claritas is just doing the same scheme now -- same stick, different carrot. If people look at the split history of Claritas, all past RS ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities